The rising geriatric population is a significant growth driver for the market. As people age, the risk of developing retinal detachment increases due to changes in the vitreous gel and other age-related factors that can lead to the pulling away of the retina from the underlying tissues.
Additionally, the elderly population is more prone to age-related eye conditions such as myopia, cataracts, and diabetic retinopathy, which further increases the risk of retinal detachment.
For instance, the prevalence of myopia in the elderly population is significantly high compared to young adults. In individuals aged 60-64 years, the prevalence ranges from 22.74% to 28.7%, while in those aged 80 years and above, it increases to 45.58% to 19.3%. Similarly, as per the CDC, an estimated 8.94 million people aged 40 years and older were living with diabetic retinopathy in 2021, and 1.71 million of those were living with vision-threatening diabetic retinopathy.
Thus, with the global population aging rapidly, the demand for retinal detachment diagnostics is expected to increase, driving market growth.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The global retinal detachment diagnostic market was valued at USD 1.1 billion in revenue in 2023 and is anticipated to grow at 6.9% CAGR between 2024 – 2032, driven by the increasing incidence of retinal detachment worldwide.
The rhegmatogenous retinal detachment segment held 48.4% of the retinal detachment diagnostic industry share in 2023, owing to the rising aging population and increasing prevalence of myopia.
North America retinal detachment diagnostic market size is anticipated to reach USD 750.2 million by 2032, attribute to the advanced healthcare infrastructure, coupled with high healthcare expenditure.
Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Centervue SpA., Essilor International, Eyenuk Inc., HealPros LLC, Millennium Surgical Corp., ONL Therapeutics, Peek Vision Ltd and Synergy Medical Systems LLP